APC announces research alliance with 4D pharma plc The APC Microbiome Institute is pleased to announce a research collaboration with 4D pharma plc to develop live biotherapeutics for Autism Spectrum Disorder (ASD) and associated CNS Disorders. The programme, worth  €4.8 million, will support several hi-tech jobs in Cork. According to Duncan Peyton, CEO of the UK-based pharmaceutical … Continue reading APC announces research alliance with 4D pharma plc